BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 22, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

NovaVision hopes to bring VRT technology to forefront

Feb. 14, 2011
By Omar Ford

CHAMPION results bolster CardioMEMS wireless sensor

Feb. 11, 2011
By Omar Ford
Daily monitoring of pulmonary artery pressures with an implantable wireless sensor in patients with heart failure led to a 39% reduction in heart-failure-related hospitalizations, according to results from the CHAMPION randomized control trial. Trial results, which evaluated CardioMEMS' (Atlanta) heart failure patient measurement system, were published in the Feb. 9 edition of the Lancet. (Medical Device Daily)
Read More

Inovio develops needle free drug-delivery device

Feb. 10, 2011
By Omar Ford

Deals roundup: Kindred to acquire RehabCare for nearly $900 million

Feb. 9, 2011
By Omar Ford
In a matter of two days the med-tech industry has seen some of its biggest deals of the year. Kindred Healthcare (Louisville Kentucky) reported that it will acquire RehabCare Group (St. Louis) for $900 million just a day after Danaher (Washington) reported that it would acquire Beckman Coulter (Brea, California) for $6.8 billion (Medical Device Daily, Feb. 8, 2011). (Medical Device Daily)
Read More

Deals roundup: Danaher to buy Beckman Coulter for $6.8 billion

Feb. 8, 2011
By Omar Ford
In one of the largest med-tech M&As in recent history, Danaher (Washington) has reported that it will acquire Beckman Coulter (Brea, California), a developer of products that simplify, automate and innovate complex biomedical testing, for nearly $6.8 billion. The merger agreement would see Danaher acquiring Beckman Coulter's outstanding common stock for $83.50 per share in cash, representing an approximate 45% premium over the closing price of Beckman Coulter's common stock on Dec. 9, 2010 before rumors of an acquisition entered the marketplace. (Medical Device Daily)
Read More

Metamark hits the mark with cancer detection test

Feb. 7, 2011
By Omar Ford

ConforMIS gets FDA OK for total knee implant

Feb. 4, 2011
By Omar Ford

Study favors Masimo's PVI to measure fluid responsiveness

Feb. 3, 2011
By Omar Ford
Hemodynamic instability is often a common problem for critically-ill patients, but the decision to administer fluid in an attempt to improve cardiac output is challenging. When necessary, fluid administration is critical to optimizing patient status and enabling end organ preservation, but unnecessary fluid administration is associated with increased morbidity and mortality. (Medical Device Daily)
Read More

Mayo Clinic launches new healthcare delivery center

Feb. 2, 2011
By Omar Ford
The debate on healthcare reform is re-emerging and it's causing physicians, hospitals and patients to once again ponder how care will be administered in the future, but one institution is taking a more hands on approach in determining an answer to this question. (Medical Device Daily)
Read More

Analysts see HeartWare taking lead in LVAD market position

Feb. 1, 2011
By Omar Ford
Previous 1 2 … 160 161 162 163 164 165 166 167 168 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • Wireframe of feet and scale

    GLP-1s need technologies for long-term use

    BioWorld
    For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • Illustration of a child's brain

    Saniona reports preclinical data for SAN-2668

    BioWorld Science
    Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing